Value-Based Calculators in Cancer: Current State and Challenges.
Explore this paper's citation graph
Summary
A timely review of value-based calculators for cancer care spending highlights both the limitations and the advantages of each value calculator and suggests opportunities for refinement.
- Type
- review
- Published
- 2017-06-15
- Cited by
- 10
- References
- 33
- Access
- Open access
- OpenAlex
- https://openalex.org/W2625701908
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:39979695
Keywords
Medicine, Current (fluid), Value (mathematics), Cancer, Medical physics
References
- Making the Grade: The Impact of Low-Grade Toxicities on Patient Preference for Treatment With Novel Agents.
- Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
- Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary
- Redefining competition in health care.
- The development of a financial toxicity patient‐reported outcome in cancer: The COST measure
- Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment.
- What is value in health care?
- Projections of the cost of cancer care in the United States: 2010-2020.
- Median-Based Incremental Cost-Effectiveness Ratio (ICER)
- Alternative pricing strategies for cancer drugs--reply.
- How physicians can change the future of health care.
- Strategies Addressing Barriers to Clinical Trial Enrollment of Underrepresented Populations: a Systematic Review
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- The Future of Cancer Care: Are We Ready For Personalized Value?
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
- Medicare innovation center oncology care model: a toe in the water when a plunge is needed.
- Valuing a QALY: review of current controversies
- New Math on Drug Cost-Effectiveness.
- Cancer statistics, 2016
- The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare.
Cited by
- MACRA in Oncology Care: Are We Ready?
- Anxiety and depression in cancer patients — what do we lose?
- Value in Oncology: It Is in the Eyes of the Beholder.
- Opportunity Costs of Receiving Palliative Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.
- The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability Rating
- The cost of chemotherapy administration: a systematic review and meta-analysis
- New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices
- Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer
- Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network
- A cost-effectiveness analysis of a silicone film-forming gel versus 10% glycerine in patients with head and neck cancer
- An Analysis of Current Value-Based Payment Frameworks applied in Oncology: A Payer Perspective
Related papers
- Genentech taps Affimed’s antibodies
- KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria
- Cardiac retransplantation in children.
- PD-09.06: Third kidney transplants: surgical aspects
- Avaliacao hemodinamica sequencial em transplante de coracao
- Thoracoscopic discectomy and fusion in the treatment of spinal deformities
- [Hepatic retransplant and acute Budd Chiari syndrome. Case report].